Inventiva S.A.
IVANASDAQHealthcare● Active
$3.88
$-0.15(-3.72%)
Market Cap$201690560
P/E Ratio—
52W High$7.983
52W Low$2.854
Inventiva S.A. (IVA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IVA · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 30, 2026EPS Actual
-$1.07
Est. -$0.23 · -365.2%
Revenue
$0.00B
Est. $0.01B · -55.3%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 30, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
IVA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 25, 2026 | -$0.43 | — | — | — | $0.00B | — |
| ▼ Q1 FY2026 | Mar 30, 2026 | -$0.23 | -$1.07 | -365.2% | $0.00B | $0.01B | -55.3% |
| ▼ Q3 FY2025 | Sep 25, 2025 | -$0.41 | -$1.89 | -361.7% | $0.01B | $0.01B | -39.8% |
| ▼ Q2 FY2025 | May 23, 2025 | -$0.47 | -$2.69 | -472.9% | $0.01B | $0.01B | +4.6% |
| ▼ Q3 FY2024 | Sep 25, 2024 | -$0.56 | -$1.01 | -81.1% | $0.00B | — | — |
| ▼ Q1 FY2024 | Mar 27, 2024 | -$0.40 | -$1.25 | -211.7% | $0.02B | $0.02B | +18.9% |
| ▼ Q3 FY2023 | Sep 28, 2023 | -$1.27 | -$1.43 | -13.1% | $0.01B | $0.00B | +419.3% |
| ▼ Q1 FY2023 | Mar 29, 2023 | -$0.57 | -$0.64 | -11.9% | $0.02B | $0.02B | +5.8% |
Q3 FY2026
Sep 25, 2026
EPS Actual
—
EPS Est.
-$0.43
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 30, 2026Miss
EPS Actual
-$1.07
EPS Est.
-$0.23
EPS Surpr.
-365.2%
Revenue
$0.00B
Q3 FY2025
Sep 25, 2025Miss
EPS Actual
-$1.89
EPS Est.
-$0.41
EPS Surpr.
-361.7%
Revenue
$0.01B
Q2 FY2025
May 23, 2025Miss
EPS Actual
-$2.69
EPS Est.
-$0.47
EPS Surpr.
-472.9%
Revenue
$0.01B
Q3 FY2024
Sep 25, 2024Miss
EPS Actual
-$1.01
EPS Est.
-$0.56
EPS Surpr.
-81.1%
Revenue
$0.00B
Q1 FY2024
Mar 27, 2024Miss
EPS Actual
-$1.25
EPS Est.
-$0.40
EPS Surpr.
-211.7%
Revenue
$0.02B
Q3 FY2023
Sep 28, 2023Miss
EPS Actual
-$1.43
EPS Est.
-$1.27
EPS Surpr.
-13.1%
Revenue
$0.01B
Q1 FY2023
Mar 29, 2023Miss
EPS Actual
-$0.64
EPS Est.
-$0.57
EPS Surpr.
-11.9%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2029 | $-0.27 | $-0.27 | $-0.27 | 1 |
| Q1 FY2029 | $-0.29 | $-0.29 | $-0.29 | 1 |
| Q4 FY2028 | $-0.29 | $-0.29 | $-0.29 | 1 |
| Q3 FY2028 | $-0.36 | $-0.36 | $-0.36 | 1 |
| Q2 FY2028 | $-0.48 | $-0.48 | $-0.48 | 1 |
| Q1 FY2028 | $-0.54 | $-0.54 | $-0.54 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Mar 30, 2026 | -365.2% | $5.72 | $5.48 | -4.20% |
| ▼ Q3 FY2025 | Sep 25, 2025 | -361.7% | $5.52 | $6.01 | +8.88% |
| ▼ Q2 FY2025 | May 23, 2025 | -472.9% | $3.13 | $3.09 | -1.28% |
| ▼ Q3 FY2024 | Sep 25, 2024 | -81.1% | $2.18 | $2.17 | -0.46% |
| ▼ Q1 FY2024 | Mar 27, 2024 | -211.7% | $3.78 | $3.82 | +1.06% |
| ▼ Q3 FY2023 | Sep 28, 2023 | -13.1% | $4.16 | $4.26 | +2.40% |
| ▼ Q1 FY2023 | Mar 29, 2023 | -11.9% | $3.90 | $3.76 | -3.59% |
| ▲ Q3 FY2022 | Sep 19, 2022 | +16.6% | $4.00 | $4.02 | +0.37% |
Q1 FY2026-4.20%
Report Date
Mar 30, 2026
EPS Beat/Miss
-365.2%
Price Before
$5.72
Price After
$5.48
Q3 FY2025+8.88%
Report Date
Sep 25, 2025
EPS Beat/Miss
-361.7%
Price Before
$5.52
Price After
$6.01
Q2 FY2025-1.28%
Report Date
May 23, 2025
EPS Beat/Miss
-472.9%
Price Before
$3.13
Price After
$3.09
Q3 FY2024-0.46%
Report Date
Sep 25, 2024
EPS Beat/Miss
-81.1%
Price Before
$2.18
Price After
$2.17
Q1 FY2024+1.06%
Report Date
Mar 27, 2024
EPS Beat/Miss
-211.7%
Price Before
$3.78
Price After
$3.82
Q3 FY2023+2.40%
Report Date
Sep 28, 2023
EPS Beat/Miss
-13.1%
Price Before
$4.16
Price After
$4.26
Q1 FY2023-3.59%
Report Date
Mar 29, 2023
EPS Beat/Miss
-11.9%
Price Before
$3.90
Price After
$3.76
Q3 FY2022+0.37%
Report Date
Sep 19, 2022
EPS Beat/Miss
+16.6%
Price Before
$4.00
Price After
$4.02
Avg Beat Reaction+0.37%
Avg Miss Reaction+0.40%
Beat Rate1 / 8 quarters
Largest Move+8.88% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IVA ends December
Inventiva S.A. (IVA) most recently reported earnings on March 30, 2026 for Q1 FY2026, posting EPS of $-1.07 — missing the analyst consensus of $-0.23 by -365.2%. The next IVA earnings date is expected around September 1, 2026.
Each quarter, investors track IVA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IVA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IVA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IVA earnings · 5 questionsInventiva S.A.'s next earnings report is expected around September 1, 2026. IVA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IVA historically reports after market close (AMC).
IVA earnings datewhen is IVA earningsIVA next earnings datewhen does IVA report earningsIVA earnings calendar
▸ Source: FMP · Inventiva S.A. SEC filings · US GAAP · Inventiva S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026